Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × Capecitabine × Clear all

NCT05007106 2025-08-14

KEYVIBE-005

Phase 2 Completed

BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT00039442 2017-08-24

Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms

NCT00016926 2013-05-27

Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms

NCT00257348 2013-02-08

Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms